Cullinan Therapeutics CEO Nadim Ahmed's 2022 pay falls 90% to $3.9M
Cullinan Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 21, 2023
Cullinan Therapeutics reported fiscal year 2022 executive compensation information on April 21, 2023.
In 2022, three executives at Cullinan Therapeutics received on average a compensation package of $2.6M, a 80% decrease compared to previous year.
Average pay of disclosed executives at Cullinan Therapeutics
Nadim Ahmed, Chief Executive Officer, received $3.9M in total, which decreased by 90% compared to 2021. 71% of Ahmed's compensation, or $2.8M, was in stock awards. Ahmed also received $371K in bonus, $618K in salary, as well as $149K in other compensation.
Patrick Baeuerle, Chief Scientific Officer, received a compensation package of $2M, which decreased by 58% compared to previous year. 35% of the compensation package, or $686K, was in option awards.
Jeffrey Trigilio, Chief Financial Officer, earned $1.9M in 2022, a 28% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 21, 2023.